MT 20 McNEIL (Pancreaze 61,000 USP units amylase; 21,000 USP units lipase; 37,000 USP units protease)
Generic Name: pancrelipase
Pill imprint MT 20 McNEIL has been identified as Pancreaze 61,000 USP units amylase; 21,000 USP units lipase; 37,000 USP units protease.
Pancreaze is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancreaze 61,000 USP units amylase; 21,000 USP units lipase; 37,000 USP units protease is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- MT 20 McNEIL
- 61,000 USP units amylase; 21,000 USP units lipase; 37,000 USP units protease
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Ortho-McNeil-Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium lauryl sulfate
More about Pancreaze (pancrelipase)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.